TOPLINE: Consuming ultraprocessed foods increases the number of episodes of gastrointestinal symptoms and intestinal inflammation in adults with established ulcerative colitis (UC). METHODOLOGY: Ultraprocessed food consumption […]

TOPLINE: Maintenance mirikizumab is well-tolerated and provides a durable response for up to 2 years in patients with ulcerative colitis who initially respond to treatment. METHODOLOGY: […]

TOPLINE: Although the combination of fecal microbiota transplantation (FMT) with bezlotoxumab was well-tolerated in patients with inflammatory bowel disease (IBD) and recurrent Clostridioides difficile infection (CDI), […]

TOPLINE: Inflammatory bowel disease (IBD) therapies for patients may need to be briefly halted during treatment for COVID-19, but it does not escalate IBD flares, with […]

A next-generation multitarget stool DNA (mt-sDNA) test for colorectal cancer (CRC) screening had higher sensitivity for all screening-relevant lesions but lower specificity than a currently available […]

TOPLINE:  A genome-wide interaction study has revealed gene variants and potential biological pathways that modify the association between diet and colorectal cancer (CRC) risk.  METHODOLOGY: A […]

TOPLINE: A comprehensive model considering patient age, diabetes, colonoscopy indications, and polyp findings can predict colorectal cancer (CRC) risk more accurately than the solely polyp-based model […]

A cell-free DNA (cfDNA) blood test, aimed at detecting abnormal DNA signals in people with an average risk of colorectal cancer (CRC), correctly detected CRC in […]

Based on a synthesis of best available evidence, the American Gastroenterological Association (AGA) has released clinical recommendations on fecal microbiota-based therapies (FMT) in adults with gastrointestinal […]